Avery Dennison shares have fallen 10.1% over the past six months to $163.83, underperforming the S&P 500's 11.4% gain, prompting a cautious outlook from analysts. The company's organic revenue grew just 2% annually over the last two years, signaling weak demand in its core business. Wall Street forecasts only 3.7% revenue growth over the next 12 months, near its five-year annualized rate of 4.3%, while earnings per share expanded at a similarly modest 4.3% annual pace. The stock now trades at 15.3 times forward earnings, a valuation deemed reasonable but not compelling, with analysts suggesting more exciting opportunities elsewhere.
Avery Dennison CorpOrganic revenue grew only 2% annually over two years, signaling weak demand in core business.